Docaravimab

Docaravimab Suppliers list
Company Name: Wuhan Maixi Biotechnology Co., Ltd  Gold
Tel: 18007167883 18007167883
Email: Service@mabnus.com
Products Intro: Product Name:Docaravimab
CAS:2247196-23-0
Purity:>98% by SDS-PAGE Package:100μg/RMB 300
Company Name: ShangHai Biochempartner Co.,Ltd  
Tel: 177-54423994 17754423994
Email: 2853530910@QQ.com
Products Intro: Product Name:Docaravimab
CAS:2247196-23-0
Purity:95% Package:100ug;500ug;1mg
Company Name: Guangzhou Hongyuan Chemical Co.,Ltd  
Tel: 15817493340
Email: 981810490@qq.com
Products Intro: Product Name:Docaravimab
CAS:2247196-23-0
Purity:95% Package:1mg;1g;100g
Company Name: Wuhan Chemstan Biotechnology Co., Ltd.  
Tel: 027-65317797 15926423062
Email: 422450190@qq.com
Products Intro: Product Name:Docaravimab
CAS:2247196-23-0
Purity:>95% Package:100ug;200ug;1mg
Company Name: Biolab Reagents  
Tel: 027-65279366 18108604356
Email: products@biolabreagent.com
Products Intro: Product Name:Research Grade Docaravimab (DVV03501)
CAS:2247196-23-0
Purity:PAGE:>95% Package:100ug;1mg
Docaravimab Basic information
Product Name:Docaravimab
Synonyms:Docaravimab;Research Grade Docaravimab (DVV03501);Research Grade Docaravimab
CAS:2247196-23-0
MF:
MW:0
EINECS:
Product Categories:
Mol File:Mol File
Docaravimab Structure
Docaravimab Chemical Properties
Safety Information
MSDS Information
Docaravimab Usage And Synthesis
UsesDocaravimab is an antibody, targeting ERA (Evelyn-Rockitniki-Abelseth) glycoprotein ectodomain epitope G-III. Docaravimab can be used in research of Rabies[1].
References[1] Wilkinson I, et, al. Systematic analysis of the varied designs of 819 therapeutic antibodies and Fc fusion proteins assigned international nonproprietary names. MAbs. 2022 Jan-Dec;14(1):2123299. DOI:10.1080/19420862.2022.2123299
Docaravimab Preparation Products And Raw materials
Tag:Docaravimab(2247196-23-0) Related Product Information
Coltuximab Ravtansine Ivonescimab Rivabazumab Research Grade Acazicolcept (DHC83404) dinutuximab Immunoglobulin G1, anti-(human interferon g) (human-mouse monoclonal HuZAF g1-chain), disulfide with human-mouse monoclonal HuZAF light chain, dimer Rocatinlimab Opucolimab Tilogotamab Miromavimab